Trial Profile
A study to evaluate the subclinical atherosclerosis after tocilizumab therapy in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 23 Jul 2015 New trial record